Lidocaine HCl injection syringes recalled due to sterility assurance failure
Nephron Sterile Compounding Center has recalled 37,310 syringes of Lidocaine HCl Injection USP 1% nationwide due to lack of assurance of sterility. Affected lots expire between August and October 2022.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of an injectable medication where sterility assurance could not be verified. No hospitalizations or illnesses have been reported. Per the severity rubric, a risk-of-harm product without reported injury is classified as High (3).
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Lidocaine HCl Injection, USP 1%, in pre-filled 5 mL syringes (10 mg/mL) nationwide. The recall encompasses 37,310 syringes due to lack of assurance of sterility.
The affected product includes syringes from four lots: LI2004A (expiration 8/6/2022), LI2005A (expiration 8/31/2022), LI2006A (expiration 9/21/2022), and LI2008A (expiration 10/11/2022). Lidocaine is a local anesthetic used in medical and dental procedures. The FDA classified this as a Class II recall. The lack of sterility assurance means that the FDA could not verify that the product remained sterile during manufacturing or storage, creating a potential health risk.
Healthcare facilities and pharmacies should stop using and distributing the affected product immediately. Patients who may have received injections from the recalled lots should contact their healthcare provider with any health concerns.
The recalled product
- Product
- Lidocaine HCl Injection, USP 1%, 50 mg/5 mL (10 mg/mL) syringe, packaged in 5 x 5 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-985-05
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable medication
- Hazard
- Affected units
- 37,310
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lots: LI2004A
- Exp. 8/6/2022
- LI2005A
- Exp. 8/31/2022
- LI2006A
- Exp. 9.21.2022
- LI2008A
- Exp. 10/11/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 37 recalled by Nephron Sterile Compounding Center LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Nephron Sterile Compounding Center LLC
See all →- HighSodium Chloride Injection Recalled for Potential Sterility Compromise
FDA (Drugs) · 2025-03-19
- HighNephron Phenylephrine HCl Injection Recalled for Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighDiltiazem HCl Injectable Drug Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-03-08
- HighFDA Recalls Norepinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2023-03-08
- HighPhenylephrine injection lacks sterility assurance; FDA recalls vials
FDA (Drugs) · 2023-03-08
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22